Sign in
Explore the registryTrack Fpi-2265's trials

TATCIST

Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).

FPI-2265OngoingActive not recruitingPhase 2Open NCT05219500 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…